Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
Arch Craniofac Surg. 2017 Mar;18(1):54-58. English. Case Report. https://doi.org/10.7181/acfs.2017.18.1.54
Hwang J , Lee YK , Burm JS .
Department of Plastic Surgery, Kyung Hee University College of Medicine, Seoul, Korea. jsburm@gmail.com
Department of Plastic Surgery, Graduate School, Kyung Hee University, Seoul, Korea.
Abstract

Lymphangioma is a congenital malformed lymphatic tumor that rarely involves the tongue. In our clinic, a 10-year-old female presented with lymphangioma circumscriptum involving the right two-thirds of the tongue. We administered an intralesional combination injection of triamcinolone, bleomycin, and bevacizumab as a treatment. Almost complete remission after combination therapy was achieved without complications such as edema, swallowing difficulties or recurrence. Bevacizumab, an inhibitor of vascular endothelial growth factor, was effective for the treatment of lymphangioma of the tongue in this case. No recurrence was noted at the 1-year follow up.

Copyright © 2019. Korean Association of Medical Journal Editors.